KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) EPS (Basic) (2016 - 2025)

Eli Lilly (LLY) has disclosed EPS (Basic) for 17 consecutive years, with $7.4 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 51.02% year-over-year to $7.4, compared with a TTM value of $23.0 through Dec 2025, up 95.58%, and an annual FY2025 reading of $23.0, up 95.58% over the prior year.
  • EPS (Basic) was $7.4 for Q4 2025 at Eli Lilly, up from $6.23 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $7.4 in Q4 2025 and bottomed at -$0.06 in Q3 2023.
  • Average EPS (Basic) over 5 years is $2.68, with a median of $2.04 recorded in 2022.
  • The sharpest move saw EPS (Basic) crashed 103.73% in 2023, then soared 1900.0% in 2024.
  • Year by year, EPS (Basic) stood at $1.9 in 2021, then grew by 13.16% to $2.15 in 2022, then rose by 13.02% to $2.43 in 2023, then soared by 101.65% to $4.9 in 2024, then surged by 51.02% to $7.4 in 2025.
  • Business Quant data shows EPS (Basic) for LLY at $7.4 in Q4 2025, $6.23 in Q3 2025, and $6.3 in Q2 2025.